argenx SE (ARGX) Revenue & Revenue Breakdown
argenx SE Revenue Highlights
Latest Revenue (Y)
$1.23B
Latest Revenue (Q)
$401.00M
Main Geography (Y)
United States
argenx SE Revenue by Period
argenx SE Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.23B | 198.56% |
| 2022-12-31 | $410.75M | -17.40% |
| 2021-12-31 | $497.28M | 1009.97% |
| 2020-12-31 | $44.80M | -42.69% |
| 2019-12-31 | $78.17M | 218.10% |
| 2018-12-31 | $24.57M | -43.75% |
| 2017-12-31 | $43.69M | 182.33% |
| 2016-12-31 | $15.47M | 106.49% |
| 2015-12-31 | $7.49M | 64.07% |
| 2014-12-31 | $4.57M | 23.56% |
| 2013-12-31 | $3.70M | 69.30% |
| 2012-12-31 | $2.18M | 49.75% |
| 2011-12-31 | $1.46M | - |
argenx SE generated $1.23B in revenue during NA 2023, up 198.56% compared to the previous quarter, and up 4990.44% compared to the same period a year ago.
argenx SE Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $401.00M | -1.58% |
| 2023-12-31 | $407.43M | 23.54% |
| 2023-09-30 | $329.79M | 21.90% |
| 2023-06-30 | $270.55M | 23.46% |
| 2023-03-31 | $219.14M | 25.83% |
| 2022-12-31 | $174.16M | 26.22% |
| 2022-09-30 | $137.98M | 83.50% |
| 2022-06-30 | $75.19M | 221.18% |
| 2022-03-31 | $23.41M | -10.03% |
| 2021-12-31 | $26.02M | 2936.41% |
| 2021-09-30 | $857.00K | -99.73% |
| 2021-06-30 | $312.24M | 97.43% |
| 2021-03-31 | $158.16M | -4354.65% |
| 2020-12-31 | $-3.72M | -132.41% |
| 2020-09-30 | $11.47M | -34.53% |
| 2019-12-31 | $17.52M | 100.63% |
| 2019-09-30 | $8.73M | 2.02% |
| 2019-06-30 | $8.56M | -79.09% |
| 2019-03-31 | $40.94M | 2779.29% |
| 2018-12-31 | $1.42M | -41.83% |
| 2018-09-30 | $2.44M | -82.34% |
| 2018-06-30 | $13.84M | 101.54% |
| 2018-03-31 | $6.87M | -33.43% |
| 2017-12-31 | $10.32M | 34.09% |
| 2017-09-30 | $7.69M | -58.56% |
| 2017-06-30 | $18.56M | 160.87% |
| 2017-03-31 | $7.12M | 93.52% |
| 2016-12-31 | $3.68M | -33.21% |
| 2016-09-30 | $5.51M | 45.64% |
| 2016-06-30 | $3.78M | 50.51% |
| 2016-03-31 | $2.51M | 32.96% |
| 2015-12-31 | $1.89M | -26.43% |
| 2015-09-30 | $2.57M | 48.66% |
| 2015-06-30 | $1.73M | 31.80% |
| 2015-03-31 | $1.31M | -26.42% |
| 2014-12-31 | $1.78M | -11.35% |
| 2014-09-30 | $2.01M | 550.83% |
| 2014-06-30 | $308.66K | -34.19% |
| 2014-03-31 | $468.99K | -49.81% |
| 2013-12-31 | $934.37K | -44.12% |
| 2013-09-30 | $1.67M | 215.10% |
| 2013-06-30 | $530.61K | -5.18% |
| 2013-03-31 | $559.63K | - |
argenx SE generated $401.00M in revenue during Q1 2024, up -1.58% compared to the previous quarter, and up 230.25% compared to the same period a year ago.
argenx SE Revenue Breakdown
argenx SE Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| China | $14.91M | - | - | - | - |
| United States | $1.05B | $377.66M | - | - | - |
| Japan | $56.43M | $15.76M | - | - | - |
| EMEA | $72.85M | - | - | - | - |
| Europe | - | $5.68M | - | - | - |
| DENMARK | - | - | $1.39M | - | - |
| Others | - | - | $123.00K | - | - |
| UNITED STATES | - | - | $317.40M | - | - |
| CHINA | - | - | $178.37M | - | - |
| U | - | - | - | $36.13M | - |
| D | - | - | - | $299.00K | $436.00K |
| L | - | - | - | - | $27.26M |
| C | - | - | - | - | $40.59M |
argenx SE's latest annual revenue breakdown by geography, as of Dec 23: United States (87.89%), EMEA (6.12%), Japan (4.74%), and China (1.25%).
Quarterly Revenue by Country
| Country | Dec 23 | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|---|---|
| United States | $605.74M | $440.85M | $94.35M | - | - | - |
| EMEA | $50.02M | $22.84M | - | - | - | - |
| Japan | $32.79M | $23.64M | $1.51M | - | - | - |
| Other | - | - | $133.00K | - | - | - |
| Countries Other Than United States And China | - | - | - | $1.24M | - | - |
| U | - | - | - | $317.26M | $22.27M | - |
| C | - | - | - | $151.90M | $15.31M | - |
| D | - | - | - | - | $120.00K | $128.00K |
| L | - | - | - | - | - | $26.60M |
argenx SE's latest quarterly revenue breakdown by geography, as of Dec 23: United States (87.97%), EMEA (7.26%), and Japan (4.76%).
argenx SE Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BGNE | BeiGene | $2.46B | $929.17M |
| ALNY | Alnylam Pharmaceuticals | $1.83B | $659.83M |
| ARGX | argenx SE | $1.23B | $401.00M |
| AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| ZLAB | Zai Lab | $266.72M | $100.50M |
| ASND | Ascendis Pharma | $266.72M | $95.89M |
| BPMC | Blueprint Medicines | $249.38M | $138.16M |
| TVTX | Travere Therapeutics | $145.24M | $54.12M |
| KRTX | Karuna Therapeutics | $654.00K | - |
| PCVX | Vaxcyte | - | - |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| TERN | Terns Pharmaceuticals | - | - |
| AKRO | Akero Therapeutics | - | - |
ARGX Revenue FAQ
What is argenx SE’s yearly revenue?
argenx SE's yearly revenue for 2023 was $1.23B, representing an increase of 198.56% compared to 2022. The company's yearly revenue for 2022 was $410.75M, representing a decrease of -17.40% compared to 2021. ARGX's yearly revenue for 2021 was $497.28M, representing an increase of 1009.97% compared to 2020.
What is argenx SE’s quarterly revenue?
argenx SE's quarterly revenue for Q1 2024 was $401M, a -1.58% decrease from the previous quarter (Q4 2023), and a 82.99% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $407.43M, a 23.54% increase from the previous quarter (Q3 2023), and a 133.94% increase year-over-year (Q4 2022). ARGX's quarterly revenue for Q3 2023 was $329.79M, a 21.90% increase from the previous quarter (Q2 2023), and a 139.01% increase year-over-year (Q3 2022).
What is argenx SE’s revenue growth rate?
argenx SE's revenue growth rate for the last 3 years (2021-2023) was 146.61%, and for the last 5 years (2019-2023) was 1468.80%.